JP2002502825A5 - - Google Patents

Download PDF

Info

Publication number
JP2002502825A5
JP2002502825A5 JP2000530228A JP2000530228A JP2002502825A5 JP 2002502825 A5 JP2002502825 A5 JP 2002502825A5 JP 2000530228 A JP2000530228 A JP 2000530228A JP 2000530228 A JP2000530228 A JP 2000530228A JP 2002502825 A5 JP2002502825 A5 JP 2002502825A5
Authority
JP
Japan
Prior art keywords
copolymer
composition
poly
block copolymer
biologically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000530228A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002502825A (ja
JP4685237B2 (ja
Filing date
Publication date
Priority claimed from US09/019,648 external-priority patent/US6277410B1/en
Application filed filed Critical
Publication of JP2002502825A publication Critical patent/JP2002502825A/ja
Publication of JP2002502825A5 publication Critical patent/JP2002502825A5/ja
Application granted granted Critical
Publication of JP4685237B2 publication Critical patent/JP4685237B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000530228A 1998-02-06 1999-02-05 経口運搬用共重合体組成物 Expired - Fee Related JP4685237B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/019,648 US6277410B1 (en) 1992-10-08 1998-02-06 Copolymer compositions for oral delivery
US09/019,648 1998-02-06
PCT/US1999/002538 WO1999039731A1 (en) 1998-02-06 1999-02-05 Copolymer compositions for oral delivery

Publications (3)

Publication Number Publication Date
JP2002502825A JP2002502825A (ja) 2002-01-29
JP2002502825A5 true JP2002502825A5 (https=) 2010-02-04
JP4685237B2 JP4685237B2 (ja) 2011-05-18

Family

ID=21794304

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000530228A Expired - Fee Related JP4685237B2 (ja) 1998-02-06 1999-02-05 経口運搬用共重合体組成物

Country Status (8)

Country Link
US (2) US6277410B1 (https=)
EP (1) EP1053010B1 (https=)
JP (1) JP4685237B2 (https=)
AT (1) ATE426397T1 (https=)
AU (1) AU2496199A (https=)
CA (1) CA2319057C (https=)
DE (1) DE69940635D1 (https=)
WO (1) WO1999039731A1 (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277410B1 (en) * 1992-10-08 2001-08-21 Supratek Pharma Inc. Copolymer compositions for oral delivery
US6153193A (en) * 1993-04-28 2000-11-28 Supratek Pharma Inc. Compositions for targeting biological agents
US6093391A (en) * 1992-10-08 2000-07-25 Supratek Pharma, Inc. Peptide copolymer compositions
US6353055B1 (en) 1994-11-18 2002-03-05 Supratek Pharma Inc. Polynucleotide compositions
IL141438A0 (en) * 2000-02-23 2002-03-10 Pfizer Prod Inc Method of increasing the bioavailability and tissue penetration of azithromycin
EP1563850A3 (en) * 2000-02-23 2008-02-20 Pfizer Products Inc. Method of increasing the bioavailability and tissue penetration of azithromycin
EP1283727A4 (en) * 2000-04-28 2007-10-10 Supratek Pharma Inc COMPOSITIONS AND METHODS FOR INDUCING ACTIVATION OF DENTRIC CELLS
US7256180B2 (en) 2000-04-28 2007-08-14 Supratek Pharma Inc. Compositions and methods for inducing activation of dendritic cells
US7259139B1 (en) * 2000-05-26 2007-08-21 Frohwitter Means for maintenance and/or correction of glucose concentration in blood
WO2002076439A2 (en) * 2001-03-23 2002-10-03 The Board Of Trustees Of The University Of Illinois Compounds capable of modulating the activity of multidrug transporters and therapeutic use of the same
GB0131112D0 (en) * 2001-12-31 2002-02-13 Univ London Pharmacy Block copolymers
CN100438861C (zh) * 2002-07-29 2008-12-03 变换药品公司 含水2,6-二异丙基苯酚药物组合物
US7550155B2 (en) * 2002-07-29 2009-06-23 Transform Pharmaceuticals Inc. Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
US20040220283A1 (en) * 2002-07-29 2004-11-04 Transform Pharmaceuticals, Inc. Aqueous 2,6-diisopropylphenol pharmaceutical compositions
SI2301965T1 (sl) 2002-10-16 2015-07-31 Purdue Pharma L.P. Protitelesa, ki vežejo celično- povezan CA 125 / O722P in metode uporabe le-teh
US7422875B2 (en) * 2004-07-20 2008-09-09 Board Of Regents Of The University Of Nebraska Compositions and methods for increasing protein production
US8017151B2 (en) * 2004-09-07 2011-09-13 Board Of Regents Of The University Of Nebraska By And Behalf Of The University Of Nebraska Medical Center Amphiphilic polymer-protein conjugates and methods of use thereof
US8168222B2 (en) * 2004-09-07 2012-05-01 Board Of Regents Of The University Of Nebraska Amphiphilic polymer-protein conjugates and methods of use thereof
WO2006099175A2 (en) * 2005-03-11 2006-09-21 Euro-Celtique S.A. Compositions comprising an anti-ca125 antibody and a cytotoxic compound and their use for the treatment of cancer
US20090306003A1 (en) * 2006-01-10 2009-12-10 Innovation Technologies, Llc Pesticide Delivery System
US8148338B2 (en) * 2006-02-22 2012-04-03 Supratek Pharma Inc. Doxorubicin formulations for anti-cancer use
RU2409363C9 (ru) * 2009-09-18 2013-12-10 Всеволод Иванович Киселев Фармацевтические композиции для пероральной доставки дииндолилметана (dim) и способы применения этих композиций
WO2013082299A1 (en) 2011-11-29 2013-06-06 Als Therapy Development Institute Targeting of t-lymphocytes to treat amyotrophic lateral sclerosis
US8912215B2 (en) * 2011-12-13 2014-12-16 Everon Biosciences, Inc. Rapamycin composition
WO2022051713A1 (en) * 2020-09-04 2022-03-10 The University Of Chicago Materials and methods of treating viral infection with amphiphilic block copolymers
US20250295771A1 (en) 2022-05-11 2025-09-25 Celgene Corporation Methods and uses related to t cell therapy and production of same

Family Cites Families (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4027013A (en) 1976-01-22 1977-05-31 William L. Wilson Clottable fibrinogen free factor VIII and albumin product and process
US4188373A (en) 1976-02-26 1980-02-12 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4106474A (en) 1977-03-17 1978-08-15 Modine Manufacturing Company Heat conserving space heater
US4865835A (en) 1982-06-02 1989-09-12 Begent Richard H J Diagnosis and treatment of tumors
EP0098110B1 (en) 1982-06-24 1989-10-18 NIHON CHEMICAL RESEARCH KABUSHIKI KAISHA also known as JAPAN CHEMICAL RESEARCH CO., LTD Long-acting composition
ES532317A0 (es) * 1983-05-16 1985-11-16 Merck & Co Inc Una composicion farmaceutica
US4474752A (en) 1983-05-16 1984-10-02 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4485457A (en) 1983-05-31 1984-11-27 Cbs Inc. Memory system including RAM and page switchable ROM
US4772466A (en) 1983-08-22 1988-09-20 Syntex (U.S.A.) Inc. Vaccines comprising polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4957735A (en) 1984-06-12 1990-09-18 The University Of Tennessee Research Corporation Target-sensitive immunoliposomes- preparation and characterization
JPS61103836A (ja) 1984-10-24 1986-05-22 Green Cross Corp:The フイブロネクチン製剤
US5183687A (en) 1985-06-18 1993-02-02 Emory University Method of treating poultry for coccidiosis
US5494660A (en) 1985-06-18 1996-02-27 Emory University Method for inhibiting microbial binding to surfaces
DE3684333D1 (de) * 1985-06-18 1992-04-16 Univ Emory Biologisch wirksame kopolymere.
US5234683A (en) 1985-06-18 1993-08-10 Emory University Method of stimulating the immune system
US5114708A (en) 1985-06-18 1992-05-19 Emory University Method for stimulating growth in animals
US5466445A (en) 1985-06-18 1995-11-14 Emory University Methods for reducing salmonella in chickens
JPS6270319A (ja) * 1985-07-30 1987-03-31 インタ−ナシヨナル・ミネラルズ・アンド・ケミカル・コ−ポレイシヨン 成長促進ホルモンの安定化
US5089260A (en) 1986-05-15 1992-02-18 Emory University Method of treating ischemic tissue
US5182106A (en) 1986-05-15 1993-01-26 Emory University Method for treating hypothermia
US5047236A (en) 1986-05-15 1991-09-10 Emory University Method of treating stroke
US5240702A (en) 1986-05-15 1993-08-31 Emory University Method of treating stroke
US4873083A (en) 1986-05-15 1989-10-10 Emory University Fibrinolytic composition
US5250294A (en) 1986-05-15 1993-10-05 Emory University Improved perfusion medium for transplantation of organs
US5152979A (en) 1986-05-15 1992-10-06 Emory University Method for treating vascular obstructions caused by abnormal cells
US5078995A (en) 1986-05-15 1992-01-07 Emory University Fibrionolytic composition
US4879109A (en) 1986-05-15 1989-11-07 Emory University Method for treating burns
US5030448A (en) 1986-05-15 1991-07-09 Emory University Method of delivering drugs to damaged or diseased tissue
US5017370A (en) 1986-05-15 1991-05-21 Emory University Improved method of performing angioplasty procedures
US5064643A (en) 1986-05-15 1991-11-12 Emory University Method for treating sickle cell disease
US4937070A (en) 1986-05-15 1990-06-26 Emory University Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids
US5648071A (en) * 1986-05-15 1997-07-15 Emory University Method of treating tumors
US4837014A (en) 1986-05-15 1989-06-06 Emory University An improved method of treating sickle cell anemia
US5039520A (en) 1986-05-15 1991-08-13 Emory University Plasma extender
US5032394A (en) 1986-05-15 1991-07-16 Emory University Method of treating burns
US5028599A (en) 1986-05-15 1991-07-02 Emory University Method of treating mycardial damage
US5080894A (en) 1986-05-15 1992-01-14 Emory University Method and composition for reducing tissue damage
US5240701A (en) 1986-05-15 1993-08-31 Emory University Method of performing angioplasty procedures
US4997644A (en) 1986-05-15 1991-03-05 Emory University Method of treating adult respiratory distress syndrome
US4897263A (en) 1986-05-15 1990-01-30 Emory University Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids
US5041288A (en) 1986-05-15 1991-08-20 Emory University Method of treating tissue damaged by reperfusion injury
US5071649A (en) 1986-05-15 1991-12-10 Emory University Method of preventing blockage in catheters
US5198211A (en) 1986-05-15 1993-03-30 Emory University Method of treating myocardial damage
US4801452A (en) 1986-05-15 1989-01-31 Hunter Robert L Fibrinolytic composition
US4882168A (en) 1986-09-05 1989-11-21 American Cyanamid Company Polyesters containing alkylene oxide blocks as drug delivery systems
JPH01501064A (ja) * 1986-09-22 1989-04-13 エモリ　ユニバーシティ ワクチンとその製法
US5554372A (en) * 1986-09-22 1996-09-10 Emory University Methods and vaccines comprising surface-active copolymers
US5567859A (en) * 1991-03-19 1996-10-22 Cytrx Corporation Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
JPH01503458A (ja) * 1987-02-20 1989-11-22 エモリ　ユニバーシティ 抗感染性化合物
US5674911A (en) * 1987-02-20 1997-10-07 Cytrx Corporation Antiinfective polyoxypropylene/polyoxyethylene copolymers and methods of use
CA1335879C (en) 1987-07-27 1995-06-13 Bruce Andrew Cornell Receptor membranes
US4853228A (en) 1987-07-28 1989-08-01 Micro-Pak, Inc. Method of manufacturing unilamellar lipid vesicles
IE911403A1 (en) * 1990-04-26 1991-11-06 Cytrx Corp Compositions and method for topical treatment of damaged or¹diseased tissue
NZ238731A (en) * 1990-06-27 1996-02-27 Univ Emory Vaccine adjuvant compositions comprising ethyleneoxy-propyleneoxy-ethyleneoxy block copolymer or a non-toxic lipopolysaccharide
US5399363A (en) * 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
ATE187154T1 (de) * 1991-03-19 1999-12-15 Cytrx Corp Polyoxypropylen/polyoxyethylen copolymere mit verbesserter biologischer aktivität
US5696298A (en) * 1991-03-19 1997-12-09 Cytrx Corporation Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
US5622649A (en) * 1991-06-27 1997-04-22 Emory University Multiple emulsions and methods of preparation
US5531925A (en) 1991-10-04 1996-07-02 Gs Biochem Ab Particles, method of preparing said particles and uses thereof
US5681812A (en) * 1991-12-10 1997-10-28 Rush Presbyterian-St. Luke's Medical Center Methods and compositions for reducing multidrug resistance
US5470568A (en) 1992-02-13 1995-11-28 Arch Development Corporation Methods and compositions of a polymer (poloxamer) for cell repair
US5573934A (en) 1992-04-20 1996-11-12 Board Of Regents, The University Of Texas System Gels for encapsulation of biological materials
KR940003548U (ko) 1992-08-14 1994-02-21 김형술 세탁물 건조기
PT619730E (pt) 1992-10-08 2001-04-30 Supratek Pharma Inc Composicao de agentes anti-neoplasticos incorporados em micelas
US6277410B1 (en) 1992-10-08 2001-08-21 Supratek Pharma Inc. Copolymer compositions for oral delivery
US5840319A (en) 1992-10-08 1998-11-24 Alakhov; Valery Yu Biological agent compositions
US6153193A (en) 1993-04-28 2000-11-28 Supratek Pharma Inc. Compositions for targeting biological agents
PT682524E (pt) 1993-02-02 2002-03-28 Xoma Technology Ltd Composicoes farmaceuticas que contem a proteina bactericida indutora da permeabilidade e um agente tensioactivo
IL106578A (en) 1993-08-03 2000-08-13 Yissum Res Dev Co Pharmaceutical compositions for drug targeting
US5417982A (en) 1994-02-17 1995-05-23 Modi; Pankaj Controlled release of drugs or hormones in biodegradable polymer microspheres
US5401296A (en) 1994-06-28 1995-03-28 Martenson; Irvin Precious metal extraction process
US5656611A (en) 1994-11-18 1997-08-12 Supratek Pharma Inc. Polynucleotide compositions
US6040295A (en) 1995-01-13 2000-03-21 Genemedicine, Inc. Formulated nucleic acid compositions and methods of administering the same for gene therapy
AUPN801296A0 (en) * 1996-02-12 1996-03-07 Csl Limited Stabilised growth hormone formulation and method of preparation thereof
JP4117922B2 (ja) * 1996-03-28 2008-07-16 武田薬品工業株式会社 徐放性製剤およびその製造法

Similar Documents

Publication Publication Date Title
JP2002502825A5 (https=)
US8349363B2 (en) Temperature responsive delivery systems
US20040247672A1 (en) Injectable sustained release compositions
US6933286B2 (en) Therapeutic delivery compositions and methods of use thereof
EP1296647B1 (en) Polymeric micelle compositions
Batrakova et al. Effects of pluronic block copolymers on drug absorption in Caco-2 cell monolayers
US7018645B1 (en) Mixtures of various triblock polyester polyethylene glycol copolymers having improved gel properties
US20040248833A1 (en) Therapeutic delivery compositions and methods of use thereof
EP0939640A1 (en) Improvements in polymer compositions for chemotherapy and methods of treatment using the same
WO2003028589A1 (en) Pla/plga oligomers combined with block copolymers for enhancing solubility of a drug in water
WO1990007923A1 (en) Transmembrane formulations for drug administration
JP2004534879A (ja) 水溶性安定性の自己集合体高分子電解質
EP3250184B1 (en) Hypotonic hydrogel formulations for enhanced transport of active agents at mucosal surfaces
JP2002502825A (ja) 経口運搬用共重合体組成物
JP2001526246A (ja) 薬剤送達及び／又は癒着防止のための方法及び組成物
KR20160123400A (ko) 자기보존 에멀젼
GB2359747A (en) An anaesthetic formulation comprising micelles and propofol
EP1691784A1 (en) Biodegradable triblock copolymers as drugs solubilizing agents and method of use
JP3819422B2 (ja) 治療用送達組成物及びその使用方法
Gu et al. Facile approach for DNA encapsulation in functional polyion complex for triggered intracellular gene delivery: design, synthesis, and mechanism
CN104379215A (zh) 雷帕霉素组合物
US20020192286A1 (en) Biodegradable triblock copolymers as solubilizing agents for drugs and method of use thereof
JP3898783B2 (ja) 生体内分解性ヒアルロン酸架橋ゲル組成物及び生体内分解性ヒアルロン酸架橋ゲル製剤
US20240382430A1 (en) Dnazyme hydrogel formulations
WO2022006137A1 (en) Methods of treating, ameliorating, or preventing coronavirus infection and/or symptoms thereof